Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)
Nephros' quarterly Liabilities from Discontinued Operations came in at 130000.0 in Q3 2022, up 80.56% quarter-over-quarter from 72000.0 in Q4 2021.
Nephros has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 130000.0 in Q3 2022.
- For the quarter ending Q3 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 130000.0; the trailing twelve-month figure through Sep 2022 stood at 130000.0 (changed N/A YoY), and the FY2021 full-year result was 72000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q3 2022 stood at 130000.0, up from 72000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 130000.0 in Q3 2022, with the low at 72000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 130,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |